Aap Implantate AG Announces Capital Increase Initiatives

aap Implantate AG has declared a rights issue and a planned capital increase against contributions in kind. The decision, approved by the Supervisory Board, aims to increase the company's share capital from EUR 14,716,976.00 to potentially EUR 16,203,539.00. This will be achieved through the issuance of up to 1,486,563 new shares, available to shareholders at a subscription price of EUR 1.35 per share with a ratio of 9.9 to 1. The subscription period is set from November 6 to 20, 2026. The goal is to enhance aap's liquidity.

In addition, the company plans to bolster its equity by up to EUR 1,350,000.00 through a debt-to-equity swap involving shareholder loans. This measure aims to improve the balance sheet by reducing loan liabilities, consequently lowering interest expenses.